Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to VLP Biotech in September, 2019 for $878,409.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AI088919-06A1 | Phase II | 878,409 | September 5, 2019 | |||||||
A SBIR Phase I contract was awarded to VLP Biotech in September, 2018 for $225,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM130245-01 | Phase I | 225,000 | September 1, 2018 | |||||||
A SBIR Phase II contract was awarded to VLP Biotech in June, 2020 for $998,145.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI142939-02 | Phase II | 998,145 | June 1, 2020 | |||||||
A SBIR Phase I contract was awarded to VLP Biotech in May, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI142939-01A1 | Phase I | 300,000 | May 1, 2019 | |||||||
A STTR Phase I contract was awarded to VLP Biotech in January, 2016 for $546,129.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI122594-01 | Phase I | 546,129 | January 15, 2016 | |||||||
A SBIR Phase I contract was awarded to VLP Biotech in February, 2016 for $224,141.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI122370-01 | Phase I | 224,141 | February 1, 2016 | |||||||
A STTR Phase I contract was awarded to VLP Biotech in July, 2014 for $509,817.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI106153-01A1 | Phase I | 509,817 | July 10, 2014 | |||||||
A SBIR Phase I contract was awarded to VLP Biotech for $599,513.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI088919-01 | Phase I | 599,513 | ||||||||
A SBIR Phase I contract was awarded to VLP Biotech for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI072785-01A1 | Phase I | 300,000 | ||||||||
A SBIR Phase II contract was awarded to VLP Biotech for $2,890,322.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI088919-03A1 | Phase II | 2,890,322 |